Neuraly Clinical Study

Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 36 Weeks of Treatment With NLY01 in Early-stage Parkinson's Disease

Neuraly Clinical Study

Principal Investigator: Chad Christine, MD

Contact: Aaron Daley, MS

415-476-9276

[email protected]

 

https://clinicaltrials.gov/ct2/show/NCT04154072